Phibro Animal Health Corporation
Phibro Animal Health Corporation (PAHC) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
pahc · stock forecast · 14 analysts (3M) · FMP · updated May 7, 2026
Analyst Rating & Consensus
Based on 14 Wall Street analysts in the past 3 months
Buy
14 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$49.00
Consensus
$49.00
+54.3% upside
Low
$49.00
Median: $49 · Last Close: $31.76
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $30.67 | ↓ 3.44% |
1-day model range: $30.32–$31.02. Peak: $31.02 (-3.44%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $41 | +30.0% |
| 2028 | $48 | +51.4% |
| 2029 | $52 | +65.2% |
| 2030 | $55 | +73.4% |
| 2031 | — | +78.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · PAHC · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-14 | Citigroup | Maintains | Neutral→Neutral |
| 2025-11-07 | JP Morgan | Maintains | Overweight→Overweight |
| 2025-08-29 | B of A Securities | Maintains | Underperform→Underperform |
| 2025-07-07 | JP Morgan | Upgrade ↑ | Neutral→Overweight |
| 2025-06-25 | Morgan Stanley | Maintains | Equal Weight→Equal Weight |
| 2025-05-08 | Morgan Stanley | Maintains | Equal Weight→Equal Weight |
| 2025-02-10 | Barclays | Maintains | Underweight→Underweight |
| 2024-12-17 | Morgan Stanley | Maintains | Equal Weight→Equal Weight |
| 2024-11-12 | Barclays | Maintains | Underweight→Underweight |
| 2024-08-30 | B of A Securities | Maintains | Underperform→Underperform |
Wall Street analysts have recently issued updated ratings on Phibro Animal Health Corporation (PAHC) stock. Of the recent 58 rating actions, 5 were upgrades and 7 were downgrades. 14 analysts currently cover PAHC.
Analyst Recommendation Trends
PAHC analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$1.5B
↓ 6.4% YoY
Revenue Next Year
$1.5B
↑ 3.3% YoY
EPS This Year
$3.07
EPS Next Year
$3.34
↑ 8.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast PAHC EPS of $3.07 for the current fiscal year, based on estimates from 3 analysts. The PAHC revenue forecast is $1.5B for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The PAHC stock forecast is supported by two independent data sources: analyst consensus ratings from 14 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus PAHC price target is $49.00 (+54.3% upside), with an analyst consensus of Buy.
The PAHC short-term stock prediction for tomorrow is $30.67 (-3.44%). The PAHC stock price prediction for 2027 estimates an average of $41. The PAHC stock prediction for 2030 projects a range of $48–$62.
Phibro Animal Health Corporation trades on NASDAQ under the ticker PAHC. The PAHC stock outlook for 2027 is broadly positive, supported by a Buy consensus among 43% of covering analysts.
Frequently asked questions
PAHC forecast · 8 questionsAccording to 14 Wall Street analysts, the average 12-month PAHC price target is $49.00, with a high forecast of $49.00 and a low of $49.00. The median price target is shown in the chart above when available. This implies +54.3% potential upside from the current price of $31.76.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.